Buy Crypto
Markets
Spot
FuturesANT
Earn
Event Center
Rewards Hub
More
100%+ PoR
BMY

Bristol-Myers Squibb Co. (BMY)

NYSE
$58.98
-$0.22
(-0.37%)
Pre-Market

Last updated: ⁦2026-11-19 11:57:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $58.98, with a market capitalization of $125.40B and a P/E ratio of 13.51. Over the past 52 weeks, its price has ranged from $45.27 to $68.64. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$125.40B

$59.53

$59.80

$58.98

$59.56

5.26K

11.02M

13.51

$68.64

$45.27

4.06%

2026-09-30

Bristol-Myers Squibb Co. (BMY) Pre-Market Stock Price

Bristol-Myers Squibb Co. (BMY) is trading at $58.98 in pre-market trading as of 2026-11-19 11:54:00, down 0.97% ($0.58) from the previous close of $59.56

Pre-market trading shows how investors are pricing BMY before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Bristol-Myers Squibb Co. (BMY) 7-Day Stock Price Change

Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $62.80 to $58.98, representing a decline of 6.08% ($3.82).

The stock traded between $58.98 and $64.94 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 9.78 million shares, down versus the previous seven-day period, indicating lower trading activity.

BMY 52-Week Price Position

Position in Range: 58.7%

52W Low$45.27
52W High$68.64

BMY is currently trading at $58.98, placing it 58.7% of the way from its 52-week low of $45.27 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bristol-Myers Squibb Co. (BMY)?

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
32,500
CEO
Christopher S. Boerner
Founded
1887
Exchange
NYSE
Company Website

BMY Stock Events

View the latest dividend and stock split events for Bristol-Myers Squibb Co.

Dividend
Ex-Dividend DateOct 2, 2026
Payment DateNov 2, 2026
Dividend Per Share$0.63

BMY News

Latest news related to Bristol-Myers Squibb Co. and BMY stock.

  • Benzinga

    Evotec, Bristol Myers Squibb Protein Degradation Partnership Receives Second FDA Investigational New Drug Acceptance For CELMoD Candidate, Phase 1 Expected In 2027

    FDA clearance expands partnered molecular glue pipelineAchievement underscores productivity of the collaboration in molecular glue discovery and potential to address patient populations with high unmet need

    Read Full Article
  • Massive

    Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors

    Bristol-Myers Squibb reported strong Q3 2026 earnings with growth portfolio revenue up 12% to $7.7 billion and eight medicines now exceeding $1 billion in annualized sales. The company advanced four late-stage clinical trials and achieved FDA clearance for Symvexis. Despite a projected $1.5-2 billion revenue decline in 2027 from European patent expirations on Eliquis, management's cost discipline ($2 billion in savings), pipeline momentum, and internal manufacturing investments position the company for long-term resilience.

    Read Full Article
  • Massive

    NSCLC Treatment Landscape Shifts as ESMO 2026 Spotlights MET, KRAS, and TROP2 Advances, Says DelveInsight

    The non-small cell lung cancer market is shifting toward precision, biomarker-guided treatment sequencing. ESMO 2026 presented Phase III data showing savolitinib plus osimertinib improved survival in MET-altered EGFR-mutated NSCLC, divarasib outperformed approved KRAS G12C inhibitors, and TROP2-directed ADCs demonstrated durable gains. The 7MM NSCLC market is projected to double from USD 33 billion in 2025 to USD 67 billion by 2036, driven by expanded screening, biomarker-driven therapies, and label expansions into earlier-stage disease.

    Read Full Article
  • Benzinga

    Bristol Myers Squibb Says KarXT Reduces Hallucinations and Delusions In Preliminary Alzheimer's Trials

    Bristol Myers Squibb reports Phase 3 ADEPT data showing KarXT reduces hallucinations, delusions, and severity in Alzheimer's psychosis.

    Read Full Article
  • Benzinga

    Bristol Myers Squibb Reports Preliminary Findings From ADEPT-1 12-Week Open-Label Lead-In Period Show Observed Improvements In Hallucination And Delusion Scores From Baseline

    Read Full Article

Ways to Trade BMY at MEXC

BMY MEXC RealStocks

Own real BMY shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

BMY Tokenized Stocks

Get BMY price exposure through a blockchain-based token.


Suitable for trading outside U.S. market hours.

  • Token tracks the BMY price
  • Trade 24/7
  • Trade on weekends and holidays

BMY Stock Futures

Trade BMY price movements with futures contracts.


Suitable for short-term positions.

  • Go long or short
  • Trade 24/7
  • Up to 20x leverage

How to Buy Bristol-Myers Squibb Co. (BMY) Stock on MEXC

Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for BMY and Place Your Order
Step 3: Search for BMY and Place Your Order
Open the RealStocks trading page and search for BMY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bristol-Myers Squibb Co. (BMY) stock price today?
Bristol-Myers Squibb Co. (BMY) is currently trading at $58.98, down 0.37% ($0.22) from the previous close of $59.56. Intraday prices update in real time during regular trading hours.
2.Is BMY stock going up or down today?
As of 2026-11-19 11:54:00, BMY is trading at $58.98, down 0.37% ($0.22) from its previous close of $59.56. The stock has traded between $58.98 and $59.80 during today’s regular session. Past price movements do not guarantee future results.
3.What is BMY pre-market price?
As of 2026-11-19 11:54:00, BMY is trading at $58.98 in pre-market trading, down 0.97% ($0.58) from the previous close of $59.56. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is BMY after-hours price?
As of 2026-11-19 11:54:00, BMY is trading at $59.52 in after-hours trading, up 0.91% ($0.54) from the regular-session close of $58.98. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is BMY stock trading now?
BMY trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does BMY sit relative to its 52-week high and low?
Over the past 52 weeks, BMY has traded between a low of $45.27 and a high of $68.64. At $58.98, the stock is positioned 58.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Bristol-Myers Squibb Co. in?
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Bristol-Myers Squibb Co.'s market capitalization and where is it listed?
Bristol-Myers Squibb Co. is listed on the NYSE exchange with a market capitalization of $125.40B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is BMY valued in terms of P/E ratio and EPS?
BMY trades at a P/E ratio of 13.51, based on trailing-twelve-month EPS of $4.54. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Bristol-Myers Squibb Co. pay a dividend?
Bristol-Myers Squibb Co. pays an indicated annual cash dividend of $2.39 per share, with a current dividend yield of 4.06% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Bristol-Myers Squibb Co.

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to BMY, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

BMY Stock Calculator

Estimate the value between BMY shares and USD.

BMY Shares to USD

BMY Shares
BMY
BMY
USD
USD
USD

1.00 BMY shares = 58.98 USD

Calculations are estimates based on the latest available price and are for reference only.